TD Cowen Reaffirms Their Hold Rating on Novartis (NVS)
In a report released today, Steve Scala from TD Cowen maintained a Hold rating on Novartis (NVS – Research Report), with a price target of ...
bovnews9h
Array Technologies Inc (ARRY) Stock Posted a Gross Margin of 27.15% Over the Past Year: Is This Justifiable?
Array Technologies Inc (ARRY) stock saw a decline, ending the day at $5.86 which represents a decrease of $-0.24 or -3.93% from the prior close of $6.1. The stock opened at $6.06 and touched a low of ...
Lam Research shares up 3%, TD Cowen called stock ‘top pick’
TD Cowen called Lam Research Corp (NASDAQ:LRCX)its top pick, given its exposure to secular trends such as increasing memory ...
bovnews14h
HAL’s Unexpected Plunge: What’s Next?
UBS has recently reduced Halliburton Company (HAL) stock to Neutral rating, as announced on December 9, 2024, according to Finviz. Earlier, on September 13, 2024, RBC Capital Mkts had reduced the ...
Market Factors: The most interesting lookahead to 2025 that I’ve seen
Market Factors features the best, most interesting lookahead to 2025 in this edition. Meanwhile, Scotiabank strategists ...
TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)
TD Cowen analyst Steve Scala maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of $45.00. The ...
Walgreens stock may be overreacting to Sycamore news: here’s why
Walgreens stock rallies on report it's considering selling itself to Sycamore Partners. TD Cowen isn't sure of the logic behind such a deal.
Thomas: We expect to see another trillion dollars deployed in AI over the next few years.
Lisa Thomas, Deputy Head of Global Research at TD Cowen, discusses the current state of the market, emphasizing the ...
Globant price target raised to $270 from $240 at TD Cowen
TD Cowen raised the firm’s price target on Globant (GLOB) to $270 from $240 and keeps a Buy rating on the shares. The firm ...